Skip to main content

Advertisement

SpringerLink
Log in

Glucose Tolerance in the Proximal Versus the Distal Small Bowel in Wistar Rats

  • Research Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Type 2 diabetes is an epidemic and insulin resistance is the central etiology of this disease. Obesity increases insulin resistance and glucose intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes. Bariatric surgery is the most effective treatment for severe obesity. Most reported series show that return to euglycemia and normal insulin levels occur days after gastric bypass and biliopancreatic diversion, long before major weight loss has taken place. The mechanisms underlying this dramatic reversal of type 2 diabetes following these bariatric procedures are not well understood.

Methods

Twelve Wistar rats were fed with a palatable hyperlipidic diet for 12 weeks. Body weight, glucose, and intraperitoneal glucose tolerance test were measured regularly. On day 91, they were randomized in two groups (hindgut and controls) and operated. Twenty-one days later, the tests were done again and the hindgut group re-operated. A duodenal exclusion was done. The results of an intraperitoneal glucose tolerance test were compared after the procedures.

Results

Body weight increased regularly in all the rats. Some rats developed hyperglycemia 28 days after beginning hyperlipidic diet, but these levels returned to baseline on days 56 and 84. The glucose tolerance test showed an improvement in glycemic levels in the hindgut group 21 days after the first operation (151 ± 21mg/dl). After the second operation, despite weight loss, the glucose tolerance test of the foregut group worsened again (267 ± 53 mg/dl) (p < 0.01).

Conclusion

Comparing the “hindgut hypothesis” and the “foregut hypothesis”, our data show an improvement in the 30 min glucose tolerance test in the hindgut group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Venkat Narayan KM, Gregg EW, Fagot-Campagna A, et al. Diabetes:a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000;50(Suppl 2):S77–84.

    Article  Google Scholar 

  2. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metabol Clin. 2003;32(4):805–22.

    Article  Google Scholar 

  3. Albu J, Pi-Sunyer FX. Obesity and diabetes. In: Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; 1998. p. 697–707.

    Google Scholar 

  4. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US:1990–1998. Diabetes Care. 2000;23:1278–83.

    Article  CAS  Google Scholar 

  5. Reaven GM, Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.

    Article  CAS  Google Scholar 

  6. Olefsky JM, Kolterman OG, Scarlett JÁ. Insulin action and resistance in obesity and noninsulin-dependent type 2 diabetes mellitus. Am J Physiol. 1982;243:E15–30.

    CAS  PubMed  Google Scholar 

  7. Albu J, Raja-Khan N. The management of the obese diabetic patient. Prim Care Clin Office Pract. 2003;30:465–91.

    Article  Google Scholar 

  8. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus 1986;35:990–8.

    Article  CAS  Google Scholar 

  9. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.

    Article  Google Scholar 

  10. Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev. 2003;(2):CD003641.

  11. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.

    Article  CAS  Google Scholar 

  12. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.

    Article  CAS  Google Scholar 

  13. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.

    Article  CAS  Google Scholar 

  14. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.

    Article  CAS  Google Scholar 

  15. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have tought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.

    Article  CAS  Google Scholar 

  16. Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998;227:637–44.

    Article  CAS  Google Scholar 

  17. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608–15.

    Article  CAS  Google Scholar 

  18. Frezza EE. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg. 2004;14:999–1005.

    Article  Google Scholar 

  19. Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–54.

    Article  CAS  Google Scholar 

  20. Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide 1 7–36: a physiological incretin in man. Lancet 1987;2:1300–04.

    Article  CAS  Google Scholar 

  21. Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003;144:5149–58.

    Article  CAS  Google Scholar 

  22. Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1258–64.

    Article  Google Scholar 

  23. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527–31.

    Article  CAS  Google Scholar 

  24. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.

    Article  Google Scholar 

  25. Estadella D, Oyama LM, Damaso AR, et al. Effect of palatable diet on lipid metabolism of sedentary and exercised rats. Nutrition 2004;20:218–24.

    Article  CAS  Google Scholar 

  26. Vivas LAM, Jamel N, Refinetti RA, et al. Anesthetic experimental device for small animal. Acta Cir Brás. 2007;22(3):229–33.

    Article  Google Scholar 

  27. Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose and beta-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 2007;142:74–85.

    Article  Google Scholar 

  28. Prada PO, Zecchin HG, Torsoni MA, et al. Western diet modulates insulin signaling, c-jun N-terminal kinase activity and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinol 2005;146:1576–87.

    Article  CAS  Google Scholar 

  29. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes. Ann Surg. 2004;239:1–11.

    Article  Google Scholar 

  30. Pacheco D, Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto_kakizaki rats. Am J Surg. 2007;194:221–4.

    Article  CAS  Google Scholar 

  31. Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Marcus Vinicius Dantas de Campos Martins, Antônio Augusto Peixoto & Christiano Costa Esposito

  2. Estácio de Sá University, Rio de Janeiro, Brazil

    Marcus Vinicius Dantas de Campos Martins

  3. Experimental Surgical Center of the Department of Surgery, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Alberto Schanaider

  4. Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Carolina Barreira Albano Aratanha

  5. Av. das Américas 1981/64, Barra da Tijuca–Rio de Janeiro, CEP: 22631-000, Brazil

    Marcus Vinicius Dantas de Campos Martins

Authors
  1. Marcus Vinicius Dantas de Campos Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antônio Augusto Peixoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Schanaider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christiano Costa Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carolina Barreira Albano Aratanha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcus Vinicius Dantas de Campos Martins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Campos Martins, M.V.D., Peixoto, A.A., Schanaider, A. et al. Glucose Tolerance in the Proximal Versus the Distal Small Bowel in Wistar Rats. OBES SURG 19, 202–206 (2009). https://doi.org/10.1007/s11695-008-9651-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-008-9651-3

Keywords

Search

Navigation